CRSP

Crispr Therapeutics AG (CRSP)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 4.83B
P/E Ratio
0.00
Revenue (TTM)
$ 38.05M
Volume
0
52W High
$ 71.13
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.80

Technicals

50-Day MA
54.0066
200-Day MA
45.0271
52 Week High
71.13
52 Week Low
30.04

About CRSP

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.

Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg